DiaMedica Therapeutics Inc. (DMAC) › Net IncomeDiaMedica Therapeutics Inc. (DMAC) — Net IncomeAnnual figures by fiscal year, from SEC filings.2017: -$4.26M2018: -$5.73M2019: -$10.65M2020: -$12.29M2021: -$13.59M2022: -$13.68M2023: -$19.38M2024: -$24.44M2025: -$32.77M-$32.77M2017Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$32.77M-34.0%2024-$24.44M-26.1%2023-$19.38M-41.7%2022-$13.68M-0.6%2021-$13.59M-10.6%2020-$12.29M-15.4%2019-$10.65M-85.7%2018-$5.73M-34.6%2017-$4.26M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share